Previously doing business as CytoDiagnostics), in November 2001 DIANON Systems, Inc. acquired UroCor Inc. UroCor is a Disease Management Organization (DMO) in urology. The firm markets a comprehensive range of integrated products and services to assist in detecting, diagnosing, treating and managing prostate cancer, bladder cancer, kidney stones and other complex urologic disorders directly to urologists and managed care organizations. UroCor's primary focus is helping urologists improve patient care and outcomes, while reducing the total cost of managing these diseases.
